Genpact Ownership

G Stock  USD 52.40  0.10  0.19%   
The majority of Genpact Limited outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Genpact to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Genpact Limited. Please pay attention to any change in the institutional holdings of Genpact Limited as this could imply that something significant has changed or is about to change at the company.
 
Shares in Circulation  
First Issued
2006-03-31
Previous Quarter
180.9 M
Current Value
179.2 M
Avarage Shares Outstanding
192.5 M
Quarterly Volatility
53.3 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genpact Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Genpact Stock Ownership Analysis

About 99.0% of the company shares are owned by institutional investors. The book value of Genpact was currently reported as 13.68. The company has Price/Earnings To Growth (PEG) ratio of 1.7. Genpact Limited last dividend was issued on the 11th of March 2025. Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. The company was founded in 1997 and is based in Hamilton, Bermuda. Genpact is traded on New York Stock Exchange in the United States. To learn more about Genpact Limited call Nallicheri Tyagarajan at (441) 298-3300 or check out https://www.genpact.com.
Besides selling stocks to institutional investors, Genpact also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Genpact's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Genpact's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

Genpact Quarterly Liabilities And Stockholders Equity

4.99 Billion

Genpact Insider Trades History

Only 1.09% of Genpact Limited are currently held by insiders. Unlike Genpact's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Genpact's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Genpact's insider trades
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

Genpact Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Genpact is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Genpact Limited backward and forwards among themselves. Genpact's institutional investor refers to the entity that pools money to purchase Genpact's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Fidelity Management And Research Company2024-12-31
20.1 M
Nalanda India Equity Fund Ltd.2024-12-31
12.7 M
Geode Capital Management, Llc2024-12-31
3.8 M
Fuller & Thaler Asset Management Inc2024-12-31
1.9 M
Bank Of New York Mellon Corp2024-12-31
1.3 M
Vulcan Value Partners, Llc2024-12-31
1.1 M
Millennium Management Llc2024-12-31
1.1 M
Note, although Genpact's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Genpact Limited Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Genpact insiders, such as employees or executives, is commonly permitted as long as it does not rely on Genpact's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Genpact insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Genpact Outstanding Bonds

Genpact issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Genpact Limited uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Genpact bonds can be classified according to their maturity, which is the date when Genpact Limited has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Genpact Corporate Filings

20th of February 2025
Other Reports
ViewVerify
F4
18th of February 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
12th of February 2025
Other Reports
ViewVerify
8K
6th of February 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify

Currently Active Assets on Macroaxis

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genpact Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Data Processing & Outsourced Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Genpact. If investors know Genpact will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Genpact listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.50)
Dividend Share
0.61
Earnings Share
2.85
Revenue Per Share
26.724
Quarterly Revenue Growth
0.089
The market value of Genpact Limited is measured differently than its book value, which is the value of Genpact that is recorded on the company's balance sheet. Investors also form their own opinion of Genpact's value that differs from its market value or its book value, called intrinsic value, which is Genpact's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genpact's market value can be influenced by many factors that don't directly affect Genpact's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Genpact's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genpact is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genpact's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.